Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $12.15 USD
Change Today +0.27 / 2.27%
Volume 55.7K
LMNS On Other Exchanges
As of 5:20 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

lumenis ltd - b (LMNS) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/2/15 - $12.45
52 Week Low
09/2/14 - $8.19
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LUMENIS LTD - B (LMNS)

Related News

No related news articles were found.

lumenis ltd - b (LMNS) Related Businessweek News

No Related Businessweek News Found

lumenis ltd - b (LMNS) Details

Lumenis Ltd., together with its subsidiaries, develops and commercializes energy-based medical systems for use in minimally invasive procedures worldwide. It operates through three segments: Surgical, Ophthalmic, and Aesthetic. The Surgical segment offers surgical laser systems and accessories used for urology/genitourinary and ENT to hospitals, outpatient clinics, ambulatory surgery centers, and medical practices. The Ophthalmic segment sells ophthalmology laser systems and accessories, such as laser links, slit lamp microscopes, laser indirect ophthalmoscopes, physician eye safety filters, surgical laser probes, and others to ophthalmic practices, outpatient clinics, and ophthalmology departments of hospitals primarily for use in retinal treatment and glaucoma/secondary cataract applications, as well as for refractive applications. The Aesthetic segment offers aesthetic laser energy-based systems to physicians primarily for skin treatment and hair removal applications. The company also provides technical training and certification of field service engineers and distributor service personnel; operates communications centers that perform installation, maintenance, and periodic and preventive servicing activities; publishes and controls the technical documentation, including service manuals and technical bulletins; and provides spare parts and logistics channels. It markets its products through a network of third-party distributors, direct sales force, and independent distributors. The company was formerly known as ESC Medical Systems Ltd. and changed its name to Lumenis Ltd. in September 2001. Lumenis Ltd. was founded in 1991 and is headquartered in Yokneam, Israel.

954 Employees
Last Reported Date: 04/2/15
Founded in 1991

lumenis ltd - b (LMNS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lumenis ltd - b (LMNS) Key Developments

Lumenis Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015 ; Provides Earnings Guidance for the Full Year Ending December 31, 2015

Lumenis announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported GAAP net income of $1.6 million or $0.05 per basic and diluted share, compared with the prior-year period's net loss of $3.1 million or $0.10 per basic and diluted share. Non-GAAP net income was $2.3 million or $0.06 per diluted share, versus $2.2 million or $0.07 per diluted share in the same quarter the previous year. Revenue was $68.5 million, up 4.1% from $65.8 million in the same quarter last year. Operating income was $3.536 million compared to the $1.586 million for the same quarter year ago. Net cash provided by operating activities was $1.308 million compared to the $4.003 million for the same quarter year ago. Purchase of property and equipment was $1.140 million compared to the $0.919 million for the same quarter year ago. Adjusted EBITDA was $5.972 million compared to the $4.847 million for the same quarter year ago. For the full year ending December 31, 2015, the company expected revenue in the range of $305 million to $310 million, representing growth of 5.3% to 7.0% year-over-year on a reported basis. The company expected Adjusted EBITDA in the range of $35 million to $37 million, representing growth of 7.9% to 14.1% year-over-year. Excluding the impact of foreign currency, Adjusted EBITDA is expected to increase 35.0% to 42.7% year-over-year. Non-GAAP EPS in the range of $0.62 to $0.66, representing growth of 9.1% to 16.1% year-over-year.

Lumenis Ltd. to Report Q1, 2015 Results on May 12, 2015

Lumenis Ltd. announced that they will report Q1, 2015 results After-Market on May 12, 2015

Lumenis Ltd., Q1 2015 Earnings Call, May 12, 2015

Lumenis Ltd., Q1 2015 Earnings Call, May 12, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LMNS:US $12.15 USD +0.27

LMNS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cynosure Inc $36.00 USD -0.69
El.En. SpA €39.25 EUR +0.55
PhotoMedex Inc $1.74 USD +0.05
Syneron Medical Ltd $11.03 USD -0.09
Zeltiq Aesthetics Inc $28.07 USD -0.35
View Industry Companies

Industry Analysis


Industry Average

Valuation LMNS Industry Range
Price/Earnings 24.6x
Price/Sales 1.5x
Price/Book 4.2x
Price/Cash Flow 24.4x
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LUMENIS LTD - B, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at